Boehringer Ingelheim, Lilly (LLY) Receive FDA Approval for Tradjenta sNDA as Add-On to Insulin Therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. IBM
2. ERAS
3. SPRO
4. TREX
5. JPM
6. AAPL
7. ORCL
8. BAC
9. NFLX
10. GS

Go back to Boehringer Ingelheim, Lilly (LLY) Receive FDA Approval for Tradjenta sNDA as Add-On to Insulin Therapy